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(Berardinelli- Seip Syndrome)
Case Report
Total generalized lipodystrophy (Berardinelli–Seip
Syndrome) is a rare hereditary disease characterized by
insulin-resistant diabetes mellitus and a small quantity of
adipose tissue and is of unknown origin. Common cardio-
vascular alterations related to this syndrome are cardiac
hypertrophy and arterial hypertension. This article re-
ports a case of Berardinelli–Seip syndrome and reviews
the literature with special emphasis on the cardiovas-
cular manifestations of this syndrome.
Total generalized lipodystrophy, also known as Berar-
dinelli-Seip syndrome, is a rare hereditary syndrome of inde-
terminate cause characterized by severe diabetes mellitus,
no ketosis/ketonuria, insulin resistance, and by the almost
total lack of subcutaneous adipose tissue 1,2. The bioche-
mical anomalies found in this syndrome have, as a basic me-
chanism, an abnormal response to insulin action and the in-
capability of producing adipose tissue 2. Other characteris-
tics include gum hypertrophy, hepatomegaly affecting liver
functions, hypertriglyceridemia, acanthosis nigricans, arte-
rial hypertension, hirsutism, nephropathy, and cardiac hy-
pertrophy 3-6. Although this syndrome was described 40
years ago, little has been reported about its cardiovascular
manifestations and its prognosis. In this study, we report a
case of total generalized lipodystrophy, accompanied by re-
view of the literature, and an analysis of the cardiovascular
manifestations of this anomaly.
Case Report
The patient is a woman with type I diabetes mellitus
and severe insulin resistance, diagnosed four years earlier,
who requires high doses of NPH insulin for clinical compen-
sation (3UI/kg weight). Since infancy, the patient has had a
history of weight loss, gigantism, and intellectual under-
development. She was admitted to the hospital with
progressive breathlessness during stress, which evolved to
breathlessness at rest and orthopnea plus edema of the
lower limbs. On clinical examination the patient weighed
40kg, was 1.70m tall, with a body mass index of 13.8kg/m2, a
thin general appearance, atrophy of the subcutaneous
cellular tissue, acanthosis nigricans in the cervical region,
gum hypertrophy, and hirsutism on the lower limbs (fig.1.)
When examined with cardiovascular apparatus, her blood
pressure was 140/100mmHg, and her heart rate was 110bpm.
She had absence of jugular turgescence, normal cardiac
ictus and bulla with a murmur of systolic ejection ++/4+ in
the left medium external border. When palpating the abdo-
men, the liver was found to be 2cm from the right costal
edge. Inferior limbs had edema +/4+. The electrocardiogram
showed sinus rhythm, a heart rate of 110 bpm, SAQRS of +
60o, PR interval 0.12s, and QT interval 0.22s. The elec-
trocardiogram had inverted, flattened waves and symmetry
in the precordial leads V4 , V5 , V6 and in D 2, D3, and AVF. The
chest X-ray showed a normal cardiac silhouette with
important, bilateral pulmonary congestion (fig. 2). The
transthoracic echocardiogram showed normal cardiac
chamber anatomy, valves and great vases with severe
symmetric hypertrophy and hyperdynamic left ventricle
performance, with the interventricular septum measuring
16mm and a mass/superficies relation, 236.17g/m2 and with
Doppler, a restrictive pattern to mitral flow (fig. 3). Magnetic
resonance imaging showed the heart in the usual position,
with intense thickening of the left ventricle wall and the
interventricular septum with limited diastolic volume (fig. 4
and 5). Abdominal ultrasound showed homogenous
hepatosplenomegaly and bilateral parenchymal ne-
phropathy. Bioimpedance showed a presence of 1% of total
body fat (normal value –20 to 26), in relation to thin mass/
fat, 66.4:1 (ideal value 2.8:1 or greater). The results of
laboratory examinations were: creatinine, 0.9mg/dL; urea,
19mg/dL; TGO, 16 UI/1; TGP, 23 UI/1; TAP, 100%; ’GAMA
GT, 65 UI/1; alkaline phosphate, 224 UI/1; hemoglobin,
7.7g/dL; hematocrit, 23%; triglycerides, 644mg/dL; total
cholesterol, 119mg/dL; cholesterol HDL, 26mg/dL; and
fasting glycemia, 222mg/dL. Fundoscopy showed light to
medium proliferating (spreading) diabetic retinopathy and
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light hypertensive retinopathy. Treatment began with loop
diuretics and calcium channel-blockers (verapamil) with
clinical improvement within 3 days. She was discharged in
functional class I.
Cardiac involvement in total generalized lipodystro-
phy has not been reported in the literature. After a review,
we found only 17 reported cases.
Bjornstad el al 4,7 described the evolution of seven
patients with congenital generalized lipodystrophy, two
women and five men, aged between 9-29 , average 20.5 age,
all with light systolic murmur at the left sternal edge, five
with symptoms of left ventricular overload on
electrocardiogram, and all with discreet cardiomegaly. In
the two-dimensional echocardiography, myocardial
hypertrophy was observed in all patients, symmetric in
four and asymmetric (septum predomination) in two
patients. The shortening fraction was normal in all cases.
On evolution, four patients died at an average age of 32
years.
Rheuban et al 5 described four cases of total generalize
lipodystrophy (16-23 years, average age 19 years) all presen-
ting with systolic murmur in the apex, with light arterial hy-
pertension in two patients. On echocardiographic evaluation,
all patients had symmetric hypertrophic cardiomyopathy,
and normal systolic function. During necropsy of one
patient, the histologic finding indicated accentuated hy-
pertrophy of fibers, without rearrangement of the fibers and
without glycogenic deposits. Geffner et al 8 report the case of
a six-month-old child with severe insulin resistance and
severe myocardial hypertrophy. Klar et al 6 report the case of
a patient, a 13- year-old girl, with severe insulin resistance,
and nonobstructive asymmetric septal hypertrophy, obser-
ved  on echocardiography, with normal systolic function.
Fig. 1 - Phenotype in total generalized lipodystrophy.
Fig. 2 - Chest X-Ray showing pulmonary congestion in the presence of normal sized
cardiac shadow.
Fig. 3 - Significant symmetrical myocardial hypertrophy demonstrated by echocar-
diography.
Fig. 4 and fig. 5 - Nuclear magnetic resonance imaging of myocardial hy-
pertrophy.
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Discussion
The case presented is a report of total generalized
lipodystrophy in which the patient presented with a thin
general appearance due to atrophy of subcutaneous
cellular tissue. The boimpedance examination confirmed
this, indicating the total presence of 1% of fat, a severe
deficit, and a common occurrence in cases of lipodystrophy
reported in literature 1,2.
Hepatomegaly 4-6,8 is a frequent finding and was also
found in our patient, in spite of her well-preserved liver
function, which is contrary to findings by Bjornstad 4.
Hypertriglyceridemia has been reported 3-6.
Acanthosis nigricans, which is found in diabetic
patients who react with hyperinsulinemia and peripheral
resistance to insulin, was also present on clinical exami-
nation.
In Bjornstad’s 7 study, myocardial hypertrophy and
ventricular diastolic dysfunction were found in greater
frequency in patients with lipodystrophy, related to the
progressive increase in age, facts found in our patient in whom
hypertrophy was considered severe. The clinical and echocar-
diographic findings and the quick clinical improvement in our
patient are indications that the diastolic dysfunction was
responsible for the exuberant status of cardiac failure obser-
ved in this patient.  The level I hypertension found does not
seem to be the cause of myocardial hypertrophy. Rheuban et al 5
found normal tension levels in half of the patients with lipo-
dystrophy with hypertrophic myocardiopathy.
Hypertrophic cardiomyopathy, which occurs in patients
with genetic insulin resistance syndrome, must be an
expression of the insulin action in the heart for its action in the
cardiac receptors of Insulin-Like growth factor I (IGF-1) 3 .
This is strongly based on the documented frequent occur-
rence of myocardial hypertrophy in children of diabetic mo-
thers and in patients with Beckwith–Wiedemann 6 syndrome.
Two hormones are important in the understanding of
the physiopathology of this syndrome: insulin and IGF-1,
which have in common their own receptors distributed in
certain organs and tissues, with similar function and
structure, that when activated promote growth and cellular
differentiation. The activation of these receivers  determines
all the clinical and biological responses produced by the
link with its hormones 3. The excess of a hormone may
activate the receiver of another hormone. When a receptor is
activated by a hormone that is not its homologue, the event
is called specificity spillover 6. In patients who are in an
insulin-resistant state and therefore, with hyperinsulinemia,
the linking of insulin to the IGF-1 3 receptors present in the
myocardial tissues results in hypertrophy of this organ, as well
as other tissues where these receptors are distributed 3,5,8. This
explains the high frequency of myocardial hypertrophy in
some cases of insulin resistance, like in lipodystrophy 6,7.
The histological differentiation from the classic hypertro-
phic cardiomyopathy is made by the absence of rearran-
gement of fibers in the myocardial hypertrophy associated
with lipodystrophy.
In conclusion, cardiac involvement seems to be the
bigger influence in the long-term prognosis of patients with
the syndrome 7, with an unfavorable characteristic due to
the anatomic and functional changes that occur as a result
of the severe 3 myocardial hypertrophy.
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